Galovan Scott Michael 4

What Happened

• Scott Michael Galovan, CFO of Avanos Medical, had 12,225 time‑based restricted share units vest on April 22, 2026. To satisfy tax withholding obligations, 4,228 shares were surrendered to the company (disposition code F) at an implied value of $24.64 per share, totaling $104,178. This was a tax‑withholding share surrender (not an open‑market sale).

Key Details

• Transaction date: April 22, 2026; filing date: April 24, 2026 (timely)
• Shares surrendered: 4,228 at $24.64 per share; total value ≈ $104,178
• Vesting covered: 12,225 TRSUs awarded April 22, 2025 and vested April 22, 2026
• Net shares issued to insider after withholding (12,225 − 4,228): 7,997 (calculation based on filing data)
• Transaction code F = shares surrendered to satisfy tax withholding; not a market sale
• Shares owned after transaction: not specified in the Form 4

Context

• This is a routine cashless withholding to cover taxes on vested restricted stock units, common for executive compensation, and does not necessarily indicate a view on the company’s stock.